Acadian Asset Management
BCRX icon

Acadian Asset Management’s BioCryst Pharmaceuticals BCRX Stock Holding History

Acadian Asset Management’s Portfolio BCRX Stock Details BCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$3.33M Sell
2025
Q1 		$5.02M Buy
2024
Q4 		$1.46M Buy
2024
Q3 		$85K Buy
2020
Q3 		– Sell
2020
Q2 		$76K Sell
2020
Q1 		$383K Buy